• Patients & Families
• Education
• Research
• Community

• Referring Physicians
• Find a Physician
• Departments & Centers
• About URMC

• Libraries
• Alumni
• Giving

URMC  » URMC Cardiovascular Science News - September 2009 » Cardiovascular Science News Stories

• Cardiovascular Science News Stories
  • Landmark NEJM Study Finds Device Therapy Prevents Heart Failure
  • Nature Article: MicroRNAs Hold Promise for Treating Blood Vessel Disease
  • Study in Nature Medicine Establishes New Target in Diseased Arteries
  • Device Significantly Reduces Blood Pressure, Improves Heart Function
  • New $76.4M Research Building Will Facilitate Cardiovascular Science
  • Johns Hopkins’ Lowenstein Named Chief of Cardiology at Rochester
  • Cardiologist Named Acting Head of Medical Center
  • AHA Recognizes Rochester’s Cardiac, Heart Failure, Stroke Care
• Division of Cardiology
• Division of Cardiothoracic Surgery

E-newsletter signup

If you would like to receive URMC Cardiovascular Science News quarterly newsletter, sign up here.

First Name:

Last Name:

Affiliation:

Email:

New $76.4M Research Building Will Facilitate Cardiovascular Science

The University of Rochester Medical Center has begun construction on its Clinical and Translational Science Building, a $76.4 million project that will serve as a hub of resources and expertise to accelerate the clinical application of biomedical research, including significant cardiovascular research. The facility is the first of its kind in the nation.

“The CTSB represents one of the cornerstones of the Medical Center’s future plans,” said cardiologist  Mark Taubman, M.D., acting CEO of the Medical Center. “This facility will make the Medical Center a more efficient and effective clinical science enterprise and a stronger competitor for government and private research dollars.”

The facility will serve as home for the University’s Clinical and Translational Science Institute, which was created in the wake of a $40 million grant from the National Institutes of Health in 2006. The grant – the largest NIH award in the School of Medicine and Dentistry’s history – was one of the first announced by the agency under a national initiative to re-engineer clinical research.

The CTSB will be occupied by 600 scientists, physicians, nurses, statisticians, research administrators, and support staff. The facility will bring together under one roof several important resources to help researchers design clinical trials, recruit participants, collect and evaluate data, and collaborate with industry and other partners. It will contain training and education programs and clinical and translational research initiatives in cardiovascular disease, neurological disorders, cancer, and other areas.

The Heart Research Follow-up Program led by world renowned cardiologist Arthur J. Moss, M.D., is one of the initiatives that will migrate to the new facility. The program currently is working with the U.S. Food and Drug Administration to develop a national repository of data to aid academic and industry researchers studying electrical activity of the heart. In addition to helping researchers understand many cardiac problems, the data may aid the development of new tools to detect drugs that can have dangerous effects on the heart.

The Clinical and Translational Science Building also will serve as coordinating center for the Upstate New York Translational Research Network – a consortium of 13 biomedical research institutions in a geographic region stretching from Albany to Buffalo. 

“Clinical research is a fundamentally multi-disciplinary undertaking requiring close coordination and collaboration among researchers and support staff,” said Thomas A. Pearson, M.D., M.P.H., Ph.D., director of the CTSI. “Bringing these resources together will help accelerate biomedical innovation, and the CTSB will have several novel architectural features that will encourage interaction among investigators and foster team-building.”

The project is expected to be completed in the summer of 2011.